InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present at World Vaccine Congress Washington 2025
Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company with commercial products and a robust development pipeline, will deliver an oral presentation and lead a panel discussion at the World Vaccine Congress Washington 2025, taking place April 22–24 in Washington, D.C. The Company will make its presentation available under the Scientific Presentations section of its website following the event. To view the full press release, visit…